AstraZeneca Pharma India Ltd (NSE:ASTRAZEN) Share Price

Company Profile

Business description
AstraZeneca Pharma India Ltd is engaged in the manufacture, trading, and marketing of pharmaceutical products. Its only operating segment is Healthcare. The company generates revenue from the sale of products such as Tablets, Injectables, and Inhalation. Geographically, it derives a majority of its revenue from India. It focuses on areas such as Cardiovascular, Renal and Metabolism (CVRM), Oncology, Respiratory, Inflammation, Autoimmunity, Neuroscience Infection and Vaccines. The company operates within India, and outside, like Cambridge, Gothenburg, and Gaithersburg. The majority of revenue is from India.
Contact
Outer Ring Road
Block N1, 12th Floor
Manyata Embassy Business Park
Rachenahalli
BangaloreKA560 045
IND
T: +91 8067748000
https://www.astrazeneca.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2026
Employees
802

Recommended

Sales growth at CSL was lower than expected but streamlining the business has its perks.

Shane Ponraj, CFA | 19 August 2025

Results were softer than expected.

Jon Mills, CFA | 19 August 2025

a2Milk announced an acquisition and a divestiture as it aims to take a bigger slice of China’s baby formula market.

Angus Hewitt, CFA | 19 August 2025

Index	Last price	Change	% Change
All Ordinaries	9,177.40	3.60	0.04%
CAC 40	7,977.25	1.83	-0.02%
DAX 40	24,360.65	62.42	-0.26%
Dow JONES (US)	44,922.27	10.45	0.02%
FTSE 100	9,211.19	21.97	0.24%
HKSE	25,165.94	43.04	0.17%
NASDAQ	21,314.95	314.82	-1.46%
Nikkei 225	42,888.55	657.74	-1.51%
NZX 50 Index	13,071.30	142.62	1.10%
S&P 500	6,411.37	37.78	-0.59%
S&P/ASX 200	8,918.00	21.80	0.25%
SSE Composite Index	3,766.21	38.92	1.04%